头颈部鳞癌根治性放疗后非癌死亡与吸入性肺炎死亡的风险因素
多因素分析显示食管癌手术史和同期食管癌放疗是非癌死亡与吸入性肺炎死亡的显著风险因素。
要点
- 下咽癌与声门上癌根治性放疗后非癌死亡占全部死亡的27.2%。
- 食管癌手术史显著增加非癌死亡(HR 3.87)与吸入性肺炎死亡(HR 6.84)风险。
- 同期食管癌放疗显著增加非癌死亡(HR 3.74)与吸入性肺炎死亡(HR 16.37)风险。
核心结论
- 对有食管癌手术史或同期食管癌放疗的下咽癌与声门上癌患者,采用放疗保留喉部的策略应谨慎。
研究设计与样本
- 回顾性队列研究,纳入2006–2014年大阪国际癌症中心391例开始根治性放疗的下咽癌与声门上癌患者。
主要发现
- 中位随访8年(范围3.6–14.1年),末次随访时202例死亡。
- 死于研究中的癌症92例(45.5%),死于其他恶性肿瘤55例(27.2%),死于非癌原因55例(27.2%)。
关键数值与推荐
- 多因素分析非癌死亡:食管癌手术史HR 3.87(p < 0.001),同期食管癌放疗HR 3.74(p = 0.006)。
- 多因素分析吸入性肺炎死亡:食管癌手术史HR 6.84(p = 0.007),同期食管癌放疗HR 16.37(p < 0.001)。
临床怎么用
- 对下咽癌与声门上癌根治性放疗患者,应评估食管癌手术史与同期食管癌放疗史以识别非癌死亡与吸入性肺炎死亡高风险者。
局限性
- 回顾性研究设计,来自单一机构数据库。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: The incidence of hypopharyngeal and supraglottic cancer (HSC) is high in Japan. This study aimed to retrospectively identify risk factors for death unrelated to cancer and death from aspiration pneumonia after definitive radiotherapy (RT) for HSC. MATERIALS AND METHODS: Overall, 391 patients who began definitive RT for HSC between 2006 and 2014 were identified from the Osaka International Cancer Institute electronic database. Among 391 patients, 33 had a history of surgery for esophageal cancer (EC) and 19 received simultaneous RT for synchronous EC. The cause of death was divided into 3 main categories: "cancer under study," "other malignancy," and "unrelated to cancer." Cox proportional hazard model was used to estimate the hazard ratio (HR). RESULTS: The median follow-up for survivors was 8 (range 3.6-14.1) years. At the last follow-up, 202 patients died. Death from "cancer under study," "other malignancy," and "unrelated to cancer" occurred in 92 (45.5%), 55 (27.2%), and 55 (27.2%) patients, respectively. Twelve patients died from aspiration pneumonia. In multivariate analysis for death unrelated to cancer and death from aspiration pneumonia, history of surgery for EC (HR: 3.87, p < 0.001; HR: 6.84, p = 0.007, respectively) and simultaneous RT for synchronous EC (HR: 3.74, p = 0.006; HR: 16.37, p < 0.001, respectively) were significant risk factors. CONCLUSION: The laryngeal preservation approach by RT for HSC patients with a history of surgery for EC and simultaneous RT for synchronous EC should be used with caution.
引用
- Kanayama N, Otozai S, Yoshii T, et al. Death unrelated to cancer and death from aspiration pneumonia after definitive radiotherapy for head and neck cancer. Radiother Oncol. 2020. PMID: 32866561. doi:10.1016/j.radonc.2020.08.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。